AstraZeneca宣布3月23日发放每股1. 595美元的股息, 收益率为156%, AstraZeneca announced a $1.595 dividend per share, payable March 23, with a 156% yield, amid institutional ownership shifts and a "Moderate Buy" analyst consensus.

2026年3月初,AstraZeneca的股票开放195.00美元,市场上限为3 024.2亿美元。 In early March 2026, AstraZeneca’s stock opened at $195.00 with a market cap of $302.42 billion. 机构投资者集体拥有公司20.35%的股份,资本国际公司和JP摩根大通公司增加了股份,而Cresset资产管理公司减少了持有量。 Institutional investors collectively owned 20.35% of the company, with Capital International Inc. and JPMorgan Chase increasing their stakes, while Cresset Asset Management reduced its holding. 该公司于2月20日宣布每股股股息为1.595美元, 3月23日向持记录股东支付, The company announced a $1.595 per share dividend, payable March 23 to shareholders of record on February 20, yielding 156.0% with a 66.26% payout ratio. 分析师保持“机动购买”共识评级和95.75美元平均目标价格,一些公司发放“购买”评级。 Analysts maintain a “Moderate Buy” consensus rating and a $95.75 average target price, with some firms issuing “buy” ratings. AstraZeneca是一家全球生物制药公司,总部设在英国剑桥,经营肿瘤、心血管、呼吸道和罕见疾病。 AstraZeneca, a global biopharmaceutical company based in Cambridge, England, operates in oncology, cardiovascular, respiratory, and rare diseases.